| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.033 | 67.608 | 71.271 | 87.057 | 100.268 | 106.489 | 136.170 | 129.123 | 115.074 | 118.359 |
| Total Income - EUR | 47.033 | 67.802 | 71.271 | 87.831 | 102.302 | 107.150 | 138.511 | 129.181 | 115.638 | 122.010 |
| Total Expenses - EUR | 39.384 | 42.172 | 42.253 | 48.366 | 39.721 | 47.237 | 60.070 | 71.230 | 75.622 | 61.707 |
| Gross Profit/Loss - EUR | 7.649 | 25.630 | 29.018 | 39.464 | 62.581 | 59.913 | 78.441 | 57.951 | 40.016 | 60.303 |
| Net Profit/Loss - EUR | 6.238 | 24.804 | 26.504 | 38.585 | 61.558 | 58.916 | 77.056 | 56.652 | 38.849 | 56.751 |
| Employees | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Beby Med-San Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.364 | 12.883 | 35.841 | 28.973 | 49.495 | 37.687 | 26.443 | 33.430 | 27.240 | 15.985 |
| Current Assets | 51.609 | 23.664 | 50.417 | 90.085 | 124.287 | 115.240 | 188.046 | 163.146 | 137.831 | 120.448 |
| Inventories | 1.911 | 1.891 | 1.859 | 1.825 | 1.790 | 0 | 0 | 0 | 1.582 | 1.573 |
| Receivables | 47.288 | 4.755 | 11.330 | 10.881 | 12.038 | 18.383 | 72.318 | 49.512 | 31.155 | 15.756 |
| Cash | 2.410 | 17.018 | 37.228 | 77.379 | 110.459 | 96.857 | 115.728 | 113.634 | 105.095 | 103.119 |
| Shareholders Funds | 60.970 | 24.848 | 50.932 | 88.582 | 148.424 | 132.062 | 206.189 | 191.227 | 163.666 | 125.534 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.003 | 11.699 | 35.326 | 30.476 | 25.358 | 20.866 | 13.364 | 5.349 | 1.405 | 10.899 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Beby Med-San Srl